Work

P-229: Real-world outcomes of sequencing elotuzumab (elo)-based regimens following daratumumab (dara) in patients with relapsed/refractory multiple myeloma: results from the Connect® MM Registry

Year: 2022

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00559-6

Authors: Sikander Ailawadhi, Brian Durie, Mohit Narang, James Omel, Lynne Wagner, Kathleen Toomey, Howard Terebelo, Hans Lee, Rafat Abonour, Cristina Gasparetto, Robert Rifkin, James Hardin, Kim Lee, Sujith Dhanasiri, Christian Gentili, Edward Yu, Ying-Ming Jou, Sundar Jagannath

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4293107951

Cites:

Cited by:

Related to: 10